Apr 18, 2023 Altasciences Completes Clinical Portion of Alzamend Neuro’s Phase IIa Multiple Ascending Dose Clinical Trial for Treatment of Dementia Related to Alzheimer’s
Dec 28, 2022 Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia
Aug 12, 2022 Alzamend Neuro aiming to rapidly develop and market safe and effective treatments for Alzheimer's
Aug 4, 2022 Alzamend Neuro Stock Pops After Benzinga Exclusive On Cognition Therapeutics Alzheimer's Data
